
Upstream Bio's CEO Rand Sutherland discusses today's severe asthma data for verekitug, a TSLP receptor antagonist
BiotechTV - News
00:00
Outro
Brad closes the interview with final thanks and well wishes for Upstream Bio's programs.
Play episode from 13:02
Transcript


